Evidence map›Paper›PMID 37994841›Full record

ArticleAnales del sistema sanitario de Navarra2023

[Management of membranoproliferative glomerulonephritis secondary to infection by hepatitis C virus].

Ignacio Lasierra Lavilla, Amalia Perona Caro, Celia Del Agua Arias-Camisón, Julien Paola Caballero Castro

Open access · diamondAbstract readCase ReportsEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Anales del sistema sanitario de Navarra, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Ignacio Lasierra LavillaServicio Aragonés de Salud. Hospital. Hospital Obispo Polanco. Servicio de Medicina Interna. Teruel. España.. ilasierral@gmail.com.
Amalia Perona CaroServicio Aragonés de Salud. Hospital. Hospital Obispo Polanco. Servicio de Nefrología. Teruel. España.. amalyapc@yahoo.es.
Celia Del Agua Arias-CamisónServicio Aragonés de Salud. Hospital. Clínico Universitario Lozano Blesa. Servicio de Anatomía Patológica. Zaragoza. España.. nacho_llac@gmail.com.
Julien Paola Caballero CastroServicio Aragonés de Salud. Hospital. Hospital Obispo Polanco. Servicio de Medicina Interna. Teruel. España.. julien2381@hotmail.com.
Servicio Aragonés de Salud · ESHospital Clínico Universitario Lozano Blesa · ESHospital Obispo Polanco · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Membranoproliferative glomerulonephritis is an uncommon condition that affects the glomeruli of the kidneys; its prevalence has decreased in our environment. Membranoproliferative glomerulonephritis has a characteristic histology that can be associated to different diseases. The clinical presentation varies, and to achieve a definitive diagnosis a renal biopsy must be done. Treatment is based on the underlying disease; when a drop in glomerular filtration rate is detected, immunosuppressants are prescribed. We describe the management of a 47-year-old female with membranoproliferative glomerulonephritis secondary to hepatitis C virus infection, a condition with very low prevalence.

Indexed as

Glomerulonephritis, MembranoproliferativeHepatitis CFemaleHepacivirusHumansKidneyMiddle AgedNephrectomy

Identifiers

PMID37994841
PMCPMC10767695
OpenAlexW4388941534

What OpenQuestion holds

Textmetadata
LicenceCC BY-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.